Skip to main content
Digital Seminar

GI Pharmacology Update

$129.99 Standard
  • How do we choose the “best treatment” for Eosinophilic Esophagitis? 
  • Why are there so many recurrences of Helicobacter pylori? 
  • What are the best options for treating C. difficile? 

Please join Clinical Gastroenterologist Dr. Peter Buch as he explores the answers to these and many other questions in this advanced, case-based, and evidence-supported training event.  At the end of this session, you will have new knowledge on the best pharmacologic practices for the most common GI concerns seen in practice. 

Here's What You'll Learn


Eosinophilic Esophagitis 
  • Proton pump inhibitor (PPI) use 
  • Swallowed steroids 
  • Elimination diet 
Helicobacter Pylori 
  • Testing regimens 
  • Clarithromycin resistance and need for quadruple therapy 
  • Pill burden and risk of recurrence 
  • How to manage refractory H pylori 
Proton pump inhibitors (PPIs) 
  • Who needs chronic therapy 
  • REAL side effects of PPIs 
Gastroparesis Diagnosis & Medication Choices 
  • Metoclopramide 
  • Erythromycin 
  • Symptomatic care 
Clostridium Difficile 
  • Should we still be using Metronidazole? 
  • Vancomycin 
  • Fidaxomicin 
  • Fecal transplants - the ultimate probiotic 
  • Bezlotoxumab 
Irritable Bowel Syndrome 
  • Are probiotics effective? 
  • OTC therapies 
  • Glutamine/Peppermint/Iberogast 
  • Antispasmodics 
  • Rifaximin 
  • Eluxadoline 
  • Lubiprostone/Linaclotide/Plecanitide/Prucalopride 
  • Antidepressants  
GI Bleeding    
  • When to use vitamin K and fresh frozen plasma  
  • When to reverse direct oral anticoagulants 
  • The management of GI bleeding and recent stent placement 
Inflammatory Bowel Disease 
  • When to consider 5 ASAs 
  • Antibiotics 
  • Steroids 
  • Antimetabolites 
  • Anti TNFs 
  • Vedolizumab 
  • Ustekinumab 
  • Tofacitiniub 
  • Biosimilars 
Opioid Induced Constipation 
  • How to choose among: Osmotic or stimulant laxatives 
  • PAMORAS: Naloxegol,Naldemedine, Methylnaltrexone 
  • Secretogogues like Lubiprostone 
  • Selective 5HT4 agonist like Prucalopride 
Liver Diseases 
  • Non-selective beta blockers to prevent variceal bleeding 
  • Statin use and the liver 
  • Acetaminophen safety in chronic liver disease 
  • Hepatitis C regimens 

Everything You're Getting


  • More than 2 hours of video content
  • CE information to come
  • Handouts and resources

Meet Your Experts


Peter Buch, MD, AGAF, FACP

Toggle speaker biography

Peter Buch, MD, AGAF, FACP, is a double board-certified clinical gastroenterologist with 35 years of experience, leads a team that treats all GI conditions, sits on editorial boards for numerous professional journals, is a highly sought-after international presenter, and hosts ReachMD GI Insights, a podcast that highlights the latest developments in gastroenterology. 
 

Dr. Buch has a passion for teaching. His style is case-based, practical, interactive, and evidence supported. Dr. Buch’s expertise has been shared with experienced clinicians and advanced-level students. He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, and the Frank H Netter School of Medicine/Quinnipiac University. 

 

Speaker Disclosures:
Financial: Dr. Peter S. Buch has employment relationships with the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, and the Frank H Netter, MD School of Medicine. He receives compensation as a professional speaker and is a podcast host with ReachMD/GI Insight. Dr. Buch receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Peter S. Buch serves on the FDA and Patient Care Committees at the American College of Gastroenterology. He serves as an editor of peer-reviewed journals. He is a member of the International Association of Medical Science Educators, the AGA Academy of Educators, the American Gastroenterological Association (AGAF), the American College of Physicians (FACP), the Hartford County Medical Association, the American College of Gastroenterology (FACG), and the Connecticut State Medical Society.

 

Content Disclosure:

Dr. Buch references the use of antidepressants for Irritable Bowel Syndrome, and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver. Dr. Buch indicates he wishes to present a fair and balanced approach to practitioners regarding such practices.

 

 

100% Satisfaction Guarantee

Register for this intensive training course without risk. If you're not completely satisfied, give us a call at 800-844-8260.

We’re that confident you'll find this learning experience to be all that's promised and more than you expected.

PESI App


Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world's best instructors, and complete your CE requirements anywhere, anytime, at your own pace.


Access for Self-Study (Non-Interactive)

Access never expires for this product.

Questions?

Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info

Want this training for your whole team?

Get a customized training package for your team at a discounted rate!


Media Type:
Digital Seminar
Product Code:
POS078420
Duration:
2 hours, 30 minutes
Copyright:
Jun 30, 2021
Closed Captions:
Available
Format:
Audio and Video

ADA Needs


We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

Some text some message..
Back to Top